MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

Allarity Therapeutics, Inc. (ALLR)

Allarity Therapeutics, Inc. (ALLR)

|||

Balance Sheets Overview

Current Ratio
111.02%
Quick Ratio
111.02%
Cash Ratio
59.42%
Debt to Asset Ratio
88.99%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Restricted cash
    • Prepaid expenses
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Promissory note, net of discount...
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
16,982
19,812
14,687
16,895
Receivables from atm sales
-
-
0
0
Restricted cash
9,999
10,000
-
-
Other current assets
61
108
265
113
Prepaid expenses
3,377
3,501
2,110
1,796
Tax credit receivable
1,310
1,082
866
1,662
Total current assets
31,729
34,503
17,928
20,466
Property, plant and equipment, net
386
420
330
330
Total assets
32,115
34,923
18,258
20,796
Accounts payable
4,113
4,235
4,282
4,602
Accrued expenses and other current liabilities
1,971
2,191
2,667
2,712
Income taxes payable
81
81
81
81
Promissory note, net of discounts and accrued interest
20,862
20,080
-
-
Derivative liability
128
-
0
0
Convertible promissory notes and accrued interest
1,424
1,416
1,400
1,390
Total current liabilities
28,579
28,003
8,430
8,785
Total liabilities
28,579
28,003
8,430
8,785
Common stock, 0.0001 par value 250,000,000 shares authorized 19,124,363 and 19,030,619 shares issued and 15,910,724 and 16,080,980 outstanding at june 30, 2026 and december 31, 2025, respectively
3
3
3
3
Additional paid-in capital
144,683
144,395
144,233
143,841
Accumulated other comprehensive loss
-1,346
-1,079
-1,021
-2,303
Accumulated deficit
-136,352
-132,947
-130,197
-126,824
Treasury stock, at cost 3,213,639 and 2,949,639 shares at june 30, 2026, and december 31, 2025, respectively
3,452
3,452
3,190
2,706
Total stockholders equity
3,536
6,920
9,828
12,011
Total liabilities and stockholders equity
32,115
34,923
18,258
20,796
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$16,982K (-4.60%↓ Y/Y)Restricted cash$9,999K Prepaid expenses$3,377K (148.86%↑ Y/Y)Tax creditreceivable$1,310K (-18.58%↓ Y/Y)Other current assets$61K (-47.41%↓ Y/Y)Total current assets$31,729K (51.94%↑ Y/Y)Property, plant andequipment, net$386K (19.88%↑ Y/Y)Total assets$32,115K (51.45%↑ Y/Y)Total liabilities andstockholders equity$32,115K (51.45%↑ Y/Y)Total liabilities$28,579K (216.21%↑ Y/Y)Total stockholdersequity$3,536K (-70.94%↓ Y/Y)Accumulated deficit-$136,352K (-9.95%↓ Y/Y)Treasury stock, at cost3,213,639 and 2,949,639...$3,452K (34.58%↑ Y/Y)Accumulated othercomprehensive loss-$1,346K (45.31%↑ Y/Y)Total currentliabilities$28,579K (216.21%↑ Y/Y)Additional paid-in capital$144,683K (2.46%↑ Y/Y)Common stock, 0.0001par value...$3K (50.00%↑ Y/Y)Promissory note, net ofdiscounts and accrued...$20,862K Accounts payable$4,113K (-10.68%↓ Y/Y)Accrued expenses andother current...$1,971K (-33.79%↓ Y/Y)Convertible promissorynotes and accrued...$1,424K (3.56%↑ Y/Y)Derivative liability$128K Income taxes payable$81K (0.00%↑ Y/Y)